Raymond James Financial Services Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,061
| Closed | -$293K | – | 2739 |
|
|
2019
Q4 | $293K | Sell |
4,061
-112
| -3% | -$8.08K | ﹤0.01% | 2331 |
|
|
2019
Q3 | $585K | Sell |
4,173
-18
| -0.4% | -$2.52K | ﹤0.01% | 1805 |
|
|
2019
Q2 | $767K | Sell |
4,191
-433
| -9% | -$79.2K | ﹤0.01% | 1654 |
|
|
2019
Q1 | $735K | Sell |
4,624
-325
| -7% | -$51.7K | ﹤0.01% | 1642 |
|
|
2018
Q4 | $474K | Sell |
4,949
-306
| -6% | -$29.3K | ﹤0.01% | 1707 |
|
|
2018
Q3 | $742K | Buy |
5,255
+481
| +10% | +$67.9K | ﹤0.01% | 1657 |
|
|
2018
Q2 | $747K | Buy |
4,774
+2,308
| +94% | +$361K | ﹤0.01% | 1607 |
|
|
2018
Q1 | $397K | Buy |
2,466
+1,025
| +71% | +$165K | ﹤0.01% | 1856 |
|
|
2017
Q4 | $237K | Sell |
1,441
-6,594
| -82% | -$1.08M | ﹤0.01% | 2150 |
|
|
2017
Q3 | $501K | Sell |
8,035
-647
| -7% | -$40.3K | ﹤0.01% | 1714 |
|
|
2017
Q2 | $691K | Buy |
8,682
+2,525
| +41% | +$201K | ﹤0.01% | 1492 |
|
|
2017
Q1 | $438K | Sell |
6,157
-1,405
| -19% | -$100K | ﹤0.01% | 1662 |
|
|
2016
Q4 | $386K | Buy |
+7,562
| New | +$386K | ﹤0.01% | 1671 |
|